<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>Erick Guerrero - Pioneering Mexican-American Clinician and Researcher by Erick Guerrero</title>
      <link>https://padlet.com/erick_guerrero/About</link>
      <description>The director of I-Lead Institute at REHD Corp., Erick Guerrero, PhD, conducts federally funded research, leadership education, and multi-industry consortia with a commitment to advancing access to health care. Among his recent accomplishments, Dr. Erick Guerrero has been awarded five grants as a principal investigator in the past couple of years. Funded by the National Institutes of Health (NIH), the grants totaled more than $8 million. He has since submitted grant applications to the NIH, CDC, PCORI and RWJF with the goal of improving responses to protect highly-impacted minority communities from the COVID-19 pandemic.

Erick Guerrero, PhD, holds distinction as one of the few Mexican-American researchers to receive NIH funding on a regular basis. He was the first Mexican national to attain a doctor of philosophy from the School of Social Service Administration (now known as the Crown Family School of Social Work, Policy and Practice) at the University of Chicago. Dr. Guerrero has become one of the foremost Latino researchers in macro social work and addiction health services research. Dr. Guerrero&#39;s 20 years of clinical experience in the treatment of substance use and mood disorders has informed culturally responsive interventions to promote minority health.
</description>
      <language>en-us</language>
      <pubDate>2021-03-20 03:36:21 UTC</pubDate>
      <lastBuildDate>2021-09-02 02:20:40 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>COVID-19 Disrupts Substance Use Treatment Services</title>
         <author>erick_guerrero</author>
         <link>https://padlet.com/erick_guerrero/About/wish/1711469044</link>
         <description><![CDATA[<div>As a result of the health risks and public safety precautions implemented in response to the COVID-19 pandemic, access to substance use treatment services has become severely restricted. According to the American Medical Association, COVID has introduced considerable barriers to collecting and distributing harm-reduction medications.</div>]]></description>
         <enclosure url="https://erick-guerrero.medium.com/covid-19-disrupts-substance-use-treatment-services-942e512aadc6" />
         <pubDate>2021-09-02 02:20:40 UTC</pubDate>
         <guid>https://padlet.com/erick_guerrero/About/wish/1711469044</guid>
      </item>
   </channel>
</rss>
